Elevation Oncology Inc (ELEV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 158,017 | N/A | N/A | N/A | N/A |
| TOTAL | $158,950 | $N/A | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 47 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 65 | 0 | 0 | 0 | 0 |
| TOTAL | $112 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $159,062 | $N/A | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 939 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 2,774 | N/A | N/A | N/A | N/A |
| TOTAL | $3,713 | $N/A | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 12 | 0 | 0 | 0 | 0 |
| TOTAL | $12 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,725 | $N/A | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 23,226 | N/A | N/A | N/A | N/A |
| Common Shares | 2 | N/A | N/A | N/A | N/A |
| Retained earnings | -33,297 | N/A | N/A | N/A | N/A |
| TOTAL | $155,337 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $159,062 | $0 | $0 | $0 | $0 |